Fertility and Sterility Publishes New Research Underscoring Importance of IVF, Fertility Preservation Access for Cancer Patients During Breast Cancer Awareness Month
October 22, 2025
For immediate release
The four articles each explore a different aspect of how fertility care intersects with cancer treatment:
- Fertility preservation for cancer: referral guidelines, treatment options, and specific considerations: As cancer incidence and survival rates increase among individuals of reproductive age, fertility preservation has become a critical component of comprehensive cancer care. Common cancer treatments like chemotherapy and radiation can significantly impair reproductive potential, yet access to fertility preservation remains inconsistent. The research paper outlines the best practices for fertility preservation for cancer patients as well as the current barriers to fertility care – including the high cost and lack of insurance coverage.
- Unassisted pregnancy rates and outcomes in cancer survivors: a systematic review: The research shows that although unassisted pregnancy is possible for patients diagnosed with cancer, certain cancers and treatments – including breast cancer – are associated with decreased live birth rates and increased complications. Individualized fertility preservation counseling throughout the cancer diagnosis and treatment process is an important aspect of comprehensive cancer care that helps patients make informed decisions about their future fertility.
- Infertility evaluation and treatment in cancer survivors: The research underscores the unique fertility needs of cancer patients, concluding that IVF remains an essential, often irreplaceable option for fertility preservation and family building.
- Fertility preservation and mental health among cancer patients of reproductive age: The paper makes the case that integrating mental health into clinical models of oncofertility care delivery is critical, highlighting how most patients who preserve fertility report feeling confident in their decision, even if preservation outcomes are not favorable, whereas patients who do not preserve fertility report higher rates of decisional regret.
As of January 1, 2025, about 18.6 million people living in the United States have a history of cancer, and this number is projected to exceed 22 million by 2035.
“Patients diagnosed with cancer already face extraordinary challenges, and worrying about whether they will have the chance to build a family should not be another burden,” said ASRM President Dr. Elizabeth Ginsburg. “IVF is often the only evidence-based treatment that allows many cancer patients to preserve their fertility and maintain hope for the future, but most insurance companies do not cover the treatment, even for cancer survivors. The US must mandate insurance coverage for IVF and fertility preservation treatments to ensure no cancer patient needs to choose between treatment and building a family.”
ASRM continues to advocate for policies that expand, rather than restrict, access to fertility care, particularly for patients whose medical circumstances, like a cancer diagnosis, make timely access to IVF critical.
Fertility and Sterility is the flagship publication of The American Society for Reproductive Medicine (ASRM). The peer-reviewed journal runs internationally and is published monthly.
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
Anna Hovey
Advocacy Engagement Specialist
E: ahovey@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Fertility in the News
ASRM, Leading Reproductive Health Organizations Attend HHS Policy Convening on Hormone Replacement Therapy (HRT)
HHS and FDA lift black box warning on estrogen therapy. ASRM joins leading orgs in support, urging evidence-based policy for women’s reproductive health.
Dr. Robert Brannigan Inaugurated President of the American Society for Reproductive Medicine
Robert E. Brannigan, MD, becomes ASRM President, bringing leadership in male fertility, fertility preservation, and reproductive urology to the forefront.
Find a Health Professional